| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/15/2004 | US20040138162 Method of resisting osteoclast formation |
| 07/15/2004 | US20040138137 Alloferons - immunomodulatory peptides |
| 07/15/2004 | US20040138135 immunogens; immunotherapy; antigen presenting cells |
| 07/15/2004 | US20040138126 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 07/15/2004 | US20040138117 administering proteins or polypeptides for prophylaxis or diagnosis of nervous system and gastrointerstinal disorders ; genetic engineering; drug screening |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040138112 Vaccines |
| 07/15/2004 | US20040137631 Processes and vectors for plastid transformation |
| 07/15/2004 | US20040137626 AAV ITR-mediated modulation |
| 07/15/2004 | US20040137621 Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures |
| 07/15/2004 | US20040137619 Method for cell culture |
| 07/15/2004 | US20040137617 Purification of antigen-specific T cells |
| 07/15/2004 | US20040137616 Corneal epithelial graft composites |
| 07/15/2004 | US20040137615 Implantable physiological or pathophysiological biosensors for measuring and monitoring cardiac and neuronal cell functions |
| 07/15/2004 | US20040137614 Human ovarian mesothelial cells and methods of isolation and uses thereof |
| 07/15/2004 | US20040137613 Biological scaffolding material |
| 07/15/2004 | US20040137612 Bone marrow multipotent stem cells for propagation of osteoblast, chrondrocytes, myoblasts, adipocytes, endothelial and neuronal tissues; tissue engineering |
| 07/15/2004 | US20040137611 Cypridina luciferase fusion for use as diagnostic tool in monitoring synaptic response |
| 07/15/2004 | US20040137601 Amino acid sequences for therapeutic and prophylactic use against diseases due to clostridium difficile toxins |
| 07/15/2004 | US20040137598 Peptidylarginine deiminase 6 |
| 07/15/2004 | US20040137595 Mfq-111, a novel human gtpase like protein |
| 07/15/2004 | US20040137590 Allene oxide cyclase gene and use thereof for producing jasmonic acid |
| 07/15/2004 | US20040137580 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering |
| 07/15/2004 | US20040137579 Protein complexes having factor VIII:C activity and production thereof |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137570 Immunoglobulin 2 |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137561 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/15/2004 | US20040137535 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 07/15/2004 | US20040137530 for diagnostic assays/genetically engineering drugs and vaccines |
| 07/15/2004 | US20040137513 Agonist anti-trk-c monoclonal antibodies |
| 07/15/2004 | US20040137510 by screening genomic DNA for mutations; solid phase synthesis; kits |
| 07/15/2004 | US20040137507 Method for separating cells |
| 07/15/2004 | US20040137506 for drug screening compunds that affect inappropriate regulation, development, or physiology of antigen presenting cells |
| 07/15/2004 | US20040137492 Novel polypeptide |
| 07/15/2004 | US20040137460 ES cells (embryonic stem cells); ECAT gene (ES cell associated transcript gene) marker to determine if the cell is an ES cell; genetic probes; use to select human stem cells or mouse stem cells |
| 07/15/2004 | US20040137450 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 07/15/2004 | US20040137447 Human sphingosine-1-phosphate phosphatase |
| 07/15/2004 | US20040137438 Encoding transporter of the inner mitochondrial membrane; able to inhibit the expression of a MCF (mitochondrial carrier family) in a host cell in antisense orientation to a promoter; use in modification of transport properties |
| 07/15/2004 | US20040137435 Human abc transporter expressed in liver,atil |
| 07/15/2004 | US20040137421 Deposition of the protein in the follicular dendritic cell of a non-human animal and detection by histology, electrophoresis or binding assay |
| 07/15/2004 | US20040137064 Compositions and processes using siRNA, amphipathic compounds and polycations |
| 07/15/2004 | US20040137051 Wound healing compositions and methods of use |
| 07/15/2004 | US20040137011 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 07/15/2004 | US20040137005 Chlamydia protein, sequence and uses thereof |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040136995 antibody, or fragment thereof, that specifically binds an ACT-4-h-1 receptor; has different binding specificity than a monoclonal antibody generated by hybridoma HBL106 |
| 07/15/2004 | US20040136974 Therapeutic platelets and methods |
| 07/15/2004 | US20040136973 Human stem cell materials and methods |
| 07/15/2004 | US20040136972 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
| 07/15/2004 | US20040136971 Implantation of encapsulated biological materials for treating diseases |
| 07/15/2004 | US20040136969 cellular composition consisting of greater than 20% adult bone marrow derived cells, depleted of hematopoietic cells and matured leucocytes; having phenotype of CD45-, Lin- and Sca+ |
| 07/15/2004 | US20040136968 Autologous cells on a support matrix for tissue repair |
| 07/15/2004 | US20040136967 Cultures, products and methods using stem cells |
| 07/15/2004 | US20040136966 implantation of hematopoietic stem cells into the myocardium surrounding an infarct following a myocardial infarction, migrate into the damaged area, where they differentiate into myocytes, endothelial cells and smooth muscle cells |
| 07/15/2004 | US20040136954 Methods and compositions for modulating T helper (Th) cell development and function |
| 07/15/2004 | US20040134502 Method for in situ repair of injured, damaged, diseased or aged articular cartilage |
| 07/15/2004 | DE10258885A1 Verfahren zur Generierung eines gentechnisch veränderten Organismus Method for generating a genetically modified organism |
| 07/15/2004 | CA2511520A1 Mammalian cell culture processes for protein production |
| 07/15/2004 | CA2510503A1 Directly injectable formulations which provide enhanced cryoprotection of cell products |
| 07/15/2004 | CA2508209A1 Preparation and administration of hybrid cell vaccines for the prevention of cancer |
| 07/14/2004 | EP1437411A1 Glucose dehydrogenase |
| 07/14/2004 | EP1437406A2 Pluripotent stem cells originating in skeletal muscle intestinal tissue |
| 07/14/2004 | EP1437404A1 Tailor-made multifunctional stem cells and utilization thereof |
| 07/14/2004 | EP1437403A1 Method of screening reporgramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs |
| 07/14/2004 | EP1437401A1 Oxidoreductase |
| 07/14/2004 | EP1437367A1 Antibody and use thereof |
| 07/14/2004 | EP1437365A1 Use of cardiotrophin in hepatic diseases |
| 07/14/2004 | EP1437364A2 Polypeptide binding to the androgen receptor and its potential use for treating breast cancer |
| 07/14/2004 | EP1437363A1 Drug transporter and use thereof |
| 07/14/2004 | EP1437147A1 METHOD OF PREPARING BASEMENT MEMBRANE, METHOD OF CONSTRUCTING BASEMENT MEMBRANE SPECIMEN,RECONSTITUTED ARTIFICIAL TISSUE USING THE BASEMENT MEMBRANE SPECIMEN AND PROCESS FOR PRODUCING THE SAME |
| 07/14/2004 | EP1437042A1 Hair follicle-reconstitution system and animal carrying the same |
| 07/14/2004 | EP1436630A2 Automated system and method for processing specimens to extract samples for both liquid-based and slide-based testing |
| 07/14/2004 | EP1436629A1 Universal microscope slide cassette |
| 07/14/2004 | EP1436624A1 A method of diagnosis and treatment and agents useful for same |
| 07/14/2004 | EP1436586A2 Automated system and method for processing multiple liquid-based specimens |
| 07/14/2004 | EP1436585A1 Apparatus and method for mixing specimens in vials |
| 07/14/2004 | EP1436430A2 Antisense modulation of fibroblast growth factor receptor 3 expression |
| 07/14/2004 | EP1436429A2 Targeted nucleic acid constructs and uses related thereto |
| 07/14/2004 | EP1436418A2 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 07/14/2004 | EP1436410A1 Use of hcv core antigen assay for screening of anti-viral compounds |
| 07/14/2004 | EP1436402A2 Coffee plant with reduced alpha-d-galactosidase activity |
| 07/14/2004 | EP1436400A1 Multi-cistronic vectors for gene transfer protocols |
| 07/14/2004 | EP1436397A2 Hepatitis c virus vaccine |
| 07/14/2004 | EP1436395A2 Methods for identifying and using modulators of estrogen related receptor gamma |
| 07/14/2004 | EP1436394A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 07/14/2004 | EP1436393A2 Rapid method of selecting cells for gene disruption by homologous recombination |
| 07/14/2004 | EP1436392A2 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 07/14/2004 | EP1436390A2 Retinoid inducible proteins of vascular smooth muscle cells and uses thereof |
| 07/14/2004 | EP1436389A2 Thrombin-cleavable chimeric proteins |
| 07/14/2004 | EP1436388A2 Novel human proteases and polynucleotides encoding the same |
| 07/14/2004 | EP1436387A2 Enzymatic conversion of blood group a, b, and ab red blood cells using alpha-n-acetylgalactosaminidases and alpha-galactosidases with unique substrate specificities and kinetic properties |
| 07/14/2004 | EP1436386A2 Method for cloning and expression of tspri restriction endonuclease and tspri methylase in e. coli |
| 07/14/2004 | EP1436385A2 Dna polymerases and mutants thereof |
| 07/14/2004 | EP1436384A2 Mutated abl kinase domains |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436381A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 07/14/2004 | EP1436330A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436326A2 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof |